Skip to main content
main-content

Insulin degludec

News

12-19-2018 | Insulin degludec | Highlight | News

Real-world data show benefits of insulin degludec vs glargine in type 2 diabetes

Insulin-naive adults with type 2 diabetes derive greater benefit from treatment with insulin degludec than from insulin glargine 300 units/mL, results from the US clinical practice-based CONFIRM study show.

10-05-2018 | Insulin degludec | EASD 2018 | News

Reducing IDeg dose before exercise may be beneficial for type 1 diabetes patients

Preliminary findings from a randomized crossover trial suggest that patients with type 1 diabetes who reduce their dose of insulin degludec before regular exercise may experience an improvement in the time spent in normoglycemia.

08-13-2018 | Insulin degludec | News

Fixed degludec–aspart co-formulation shows promise in pediatric diabetes

The fixed soluble co-formulation of insulin degludec/insulin aspart offers similar glycemic control to insulin detemir when each are combined with mealtime insulin aspart in children with type 1 diabetes, research shows.

Read more

Related topics

Superior

Related

Opinion

11-08-2017 | Long-acting insulins | Editorial | Article

Longer-acting basal insulin analogs: What, how, why, when, and who?

Advisory Board member and pharmacist, Josh Neumiller, presents a practical guide to support clinical decision-making in the initiation and titration of U-300 insulin glargine and insulin degludec.

Journal articles and book chapters

11-03-2018 | Premixed insulins | Review | Article

Expert opinion: Patient selection for premixed insulin formulations in diabetes care

Kalra S et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0521-2

08-16-2018 | Pregnancy | Review | Article

Glucose targets and insulin choice in pregnancy: What has changed in the last decade?

Bacon S, Feig DS. Curr Diab Rep 2018; 18: 77. doi: 10.1007/s11892-018-1054-9

06-22-2018 | Gastroparesis | Review | Article

Diabetic gastroparesis: Principles and current trends in management

Krishnasamy S, Abell TL. Diabetes Ther (2018); 9 (Suppl 1): 1. doi: 10.1007/s13300-018-0454-9

Case reports

03-29-2018 | Pregnancy | Case report | Article

Empagliflozin, metformin, and insulin degludec, during pregnancy: A case report

Formoso G et al. Acta Diabetol 2018; 55: 759. doi: 10.1007/s00592-018-1134-y

image credits